应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PLX Protalix BioTherapeutics Inc
耶稣受难日休市 03-28 16:00:00 EDT
1.26
+0.01
+0.80%
盘后
1.26
+0.00
0.00%
17:17 EDT
最高
1.28
最低
1.24
成交量
28.24万
今开
1.24
昨收
1.25
日振幅
3.20%
总市值
9,205万
流通市值
8,158万
总股本
7,305万
成交额
35.73万
换手率
0.44%
流通股本
6,475万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Protalix Biotherapeutics Inc盘中异动 股价大涨5.52%
自选股智能写手 · 02-27
Protalix Biotherapeutics Inc盘中异动 股价大涨5.52%
Protalix Biotherapeutics Inc盘中异动 快速跳水5.10%
自选股智能写手 · 01-24
Protalix Biotherapeutics Inc盘中异动 快速跳水5.10%
Protalix Biotherapeutics Inc盘中异动 快速跳水5.56%报1.62美元
自选股智能写手 · 01-12
Protalix Biotherapeutics Inc盘中异动 快速跳水5.56%报1.62美元
Protalix Biotherapeutics Inc盘中异动 早盘快速拉升5.00%
自选股智能写手 · 2023-12-26
Protalix Biotherapeutics Inc盘中异动 早盘快速拉升5.00%
Protalix Biotherapeutics Inc盘中异动 股价大涨5.23%报1.81美元
自选股智能写手 · 2023-12-19
Protalix Biotherapeutics Inc盘中异动 股价大涨5.23%报1.81美元
Protalix Biotherapeutics Inc盘中异动 急速上涨5.06%
自选股智能写手 · 2023-12-14
Protalix Biotherapeutics Inc盘中异动 急速上涨5.06%
Protalix Biotherapeutics Inc盘中异动 急速拉升5.24%
自选股智能写手 · 2023-12-01
Protalix Biotherapeutics Inc盘中异动 急速拉升5.24%
加载更多
公司概况
公司名称:
Protalix BioTherapeutics Inc
所属市场:
AMEX
上市日期:
--
主营业务:
Protalix Biotherapeutics, Inc.最初于1992年4月在佛罗里达州注册成立,并于2016年3月在特拉华州重新注册成立。该公司是一家生物制药公司,专注于开发、生产和商业化由专有的ProCellEx植物细胞蛋白表达系统生产的重组治疗蛋白。该公司是第一家也是唯一一家获得FDA批准的通过植物细胞表达悬浮蛋白生产的公司。该公司独特的表达系统代表了一种以工业规模开发重组蛋白的新方法。该公司的战略重点是开发主要通过ProCellEx生产的定制复杂重组治疗性蛋白质,同时在生产前和生产后对蛋白质进行基因工程和化学修饰。该公司打算通过改进治疗蛋白的生物学特性(例如,糖基化、半衰期、免疫原性),进行此类工程设计和修改,以提供额外的临床益处。
发行价格:
--
{"stockData":{"symbol":"PLX","market":"US","secType":"STK","nameCN":"Protalix BioTherapeutics Inc","latestPrice":1.26,"timestamp":1711656000000,"preClose":1.25,"halted":0,"volume":282403,"hourTrading":{"tag":"盘后","latestPrice":1.26,"preClose":1.26,"latestTime":"17:17 EDT","volume":7730,"amount":9739.8,"timestamp":1711660671967},"delay":0,"floatShares":64747463,"shares":73052124,"eps":0.086673,"marketStatus":"耶稣受难日休市","marketStatusCode":7,"change":0.01,"latestTime":"03-28 16:00:00 EDT","open":1.24,"high":1.28,"low":1.24,"amount":357349.2826431,"amplitude":0.032,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.086673,"exchange":"AMEX","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1711958400000},"adr":0,"listingDate":829022400000,"adjPreClose":1.25,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.2498,"preClose":1.25,"latestTime":"08:33 EDT","volume":372,"amount":464.6915748,"timestamp":1711629233781},"postHourTrading":{"tag":"盘后","latestPrice":1.26,"preClose":1.26,"latestTime":"17:17 EDT","volume":7730,"amount":9739.8,"timestamp":1711660671967},"volumeRatio":0.7072618290483141},"requestUrl":"/m/hq/s/PLX","defaultTab":"news","newsList":[{"id":"2414830085","title":"Protalix Biotherapeutics Inc盘中异动 股价大涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414830085","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414830085?lang=zh_cn&edition=full","pubTime":"2024-02-27 01:13","pubTimestamp":1708967616,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日01时13分,Protalix Biotherapeutics Inc股票出现波动,股价大幅拉升5.52%。Protalix Biotherapeutics Inc股票所在的生物技术行业中,整体涨幅为0.08%。其相关个股中,Zyversa Therapeutics Inc、Ocean Biomedical Inc、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大,Zyversa Therapeutics Inc、Ocean Biomedical Inc、Neubase Therapeutics Inc较为活跃,换手率分别为1642.81%、203.37%、81.25%,振幅较大的相关个股有Zyversa Therapeutics Inc、Ocean Biomedical Inc、Seastar Medical Holding Corp C/Wts 28/10/2027 ,振幅分别为158.55%、85.99%、81.21%。Protalix Biotherapeutics Inc公司简介:Protalix BioTherapeutics Inc是一家生物制药公司,专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402270113367a46f4ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402270113367a46f4ab&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2405715461","title":"Protalix Biotherapeutics Inc盘中异动 快速跳水5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2405715461","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2405715461?lang=zh_cn&edition=full","pubTime":"2024-01-24 00:24","pubTimestamp":1706027092,"startTime":"0","endTime":"0","summary":"北京时间2024年01月24日00时24分,Protalix Biotherapeutics Inc股票出现异动,股价急速下跌5.10%。Protalix Biotherapeutics Inc股票所在的生物技术行业中,整体跌幅为0.19%。其相关个股中,Ensysce Biosciences Inc、Tc Biopharm Plc C/Wts 10/02/2028 、Outlook Therapeutics Inc涨幅较大,Ensysce Biosciences Inc、Transcode Therapeutics Inc、Kintara Therapeutics Inc较为活跃,换手率分别为932.90%、149.04%、35.95%,振幅较大的相关个股有Ys Biopharma Co Ltd C/Wts 15/03/2028 、Ocean Biomedical Inc C/Wts 14/02/2028 、Revelation Biosciences Inc,振幅分别为70.54%、53.20%、42.14%。Protalix Biotherapeutics Inc公司简介:Protalix BioTherapeutics Inc是一家生物制药公司,专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401240024527a3db0b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401240024527a3db0b8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402089364","title":"Protalix Biotherapeutics Inc盘中异动 快速跳水5.56%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402089364","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402089364?lang=zh_cn&edition=full","pubTime":"2024-01-12 00:42","pubTimestamp":1704991330,"startTime":"0","endTime":"0","summary":"北京时间2024年01月12日00时42分,Protalix Biotherapeutics Inc股票出现异动,股价大幅跳水5.56%。截至发稿,该股报1.62美元/股,成交量7.8469万股,换手率0.11%,振幅4.06%。Protalix Biotherapeutics Inc股票所在的生物技术行业中,整体跌幅为0.61%。Protalix Biotherapeutics Inc公司简介:Protalix BioTherapeutics Inc是一家生物制药公司,专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240112004210790827e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240112004210790827e1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2394247287","title":"Protalix Biotherapeutics Inc盘中异动 早盘快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2394247287","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2394247287?lang=zh_cn&edition=full","pubTime":"2023-12-26 23:30","pubTimestamp":1703604638,"startTime":"0","endTime":"0","summary":"北京时间2023年12月26日23时30分,Protalix Biotherapeutics Inc股票出现波动,股价快速上涨5.00%。Protalix Biotherapeutics Inc股票所在的生物技术行业中,整体涨幅为0.24%。其相关个股中,Rayzebio Inc、Apollomics Inc C/Wts 01/04/2028 、亘喜生物涨幅较大,60 Degrees Pharmaceuticals Inc、Brainstrom Cell Therapeutics、Onconetix Inc较为活跃,换手率分别为223.31%、37.04%、16.84%,振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Celularity Inc C/Wts 16/07/2026 、60 Degrees Pharmaceuticals Inc,振幅分别为74.00%、61.58%、34.38%。Protalix Biotherapeutics Inc公司简介:Protalix BioTherapeutics Inc是一家生物制药公司,专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122623303887e61b2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122623303887e61b2c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2392799204","title":"Protalix Biotherapeutics Inc盘中异动 股价大涨5.23%报1.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2392799204","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2392799204?lang=zh_cn&edition=full","pubTime":"2023-12-19 00:29","pubTimestamp":1702916958,"startTime":"0","endTime":"0","summary":"北京时间2023年12月19日00时29分,Protalix Biotherapeutics Inc股票出现异动,股价快速上涨5.23%。截至发稿,该股报1.81美元/股,成交量37.2104万股,换手率0.51%,振幅5.81%。Protalix Biotherapeutics Inc股票所在的生物技术行业中,整体跌幅为0.50%。Protalix Biotherapeutics Inc公司简介:Protalix BioTherapeutics Inc是一家生物制药公司,专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312190029187a343f17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312190029187a343f17&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2391980855","title":"Protalix Biotherapeutics Inc盘中异动 急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2391980855","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2391980855?lang=zh_cn&edition=full","pubTime":"2023-12-14 01:16","pubTimestamp":1702487808,"startTime":"0","endTime":"0","summary":"北京时间2023年12月14日01时16分,Protalix Biotherapeutics Inc股票出现波动,股价急速上涨5.06%。Protalix Biotherapeutics Inc股票所在的生物技术行业中,整体涨幅为2.78%。其相关个股中,Protagenic Therapeutics Inc C/Wts 29/04/2026 、Shattuck Labs Inc、C4 Therapeutics Inc涨幅较大,Scisparc Ltd、C4 Therapeutics Inc、Aditxt Inc较为活跃,换手率分别为977.60%、274.13%、250.28%,振幅较大的相关个股有Avalo Therapeutics Inc、Tc Biopharm Plc C/Wts 10/02/2028 、Shattuck Labs Inc,振幅分别为116.71%、110.74%、82.93%。Protalix Biotherapeutics Inc公司简介:Protalix BioTherapeutics Inc是一家生物制药公司,专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121401164884767307&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121401164884767307&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2388735064","title":"Protalix Biotherapeutics Inc盘中异动 急速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2388735064","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2388735064?lang=zh_cn&edition=full","pubTime":"2023-12-01 04:49","pubTimestamp":1701377374,"startTime":"0","endTime":"0","summary":"北京时间2023年12月01日04时49分,Protalix Biotherapeutics Inc股票出现异动,股价快速上涨5.24%。Protalix Biotherapeutics Inc股票所在的生物技术行业中,整体涨幅为1.09%。其相关个股中,安皮奥制药、Soligenix Inc、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大,安皮奥制药、Aditxt Inc、Clearmind Medicine Inc较为活跃,换手率分别为2153.40%、1584.46%、1023.39%,振幅较大的相关个股有Soligenix Inc、安皮奥制药、Neubase Therapeutics Inc,振幅分别为353.73%、265.83%、135.17%。Protalix Biotherapeutics Inc公司简介:Protalix BioTherapeutics Inc是一家生物制药公司,专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120104493578ff85f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120104493578ff85f8&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.protalix.com","stockEarnings":[{"period":"1week","weight":-0.0455},{"period":"1month","weight":-0.1923},{"period":"3month","weight":-0.2921},{"period":"6month","weight":-0.241},{"period":"1year","weight":-0.3762},{"period":"ytd","weight":-0.2921}],"compareEarnings":[{"period":"1week","weight":0.0017},{"period":"1month","weight":0.0318},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.2236},{"period":"1year","weight":0.3033},{"period":"ytd","weight":0.1005}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Protalix Biotherapeutics, Inc.最初于1992年4月在佛罗里达州注册成立,并于2016年3月在特拉华州重新注册成立。该公司是一家生物制药公司,专注于开发、生产和商业化由专有的ProCellEx植物细胞蛋白表达系统生产的重组治疗蛋白。该公司是第一家也是唯一一家获得FDA批准的通过植物细胞表达悬浮蛋白生产的公司。该公司独特的表达系统代表了一种以工业规模开发重组蛋白的新方法。该公司的战略重点是开发主要通过ProCellEx生产的定制复杂重组治疗性蛋白质,同时在生产前和生产后对蛋白质进行基因工程和化学修饰。该公司打算通过改进治疗蛋白的生物学特性(例如,糖基化、半衰期、免疫原性),进行此类工程设计和修改,以提供额外的临床益处。","yearOnYearQuotes":[{"month":1,"riseRate":0.705882,"avgChangeRate":0.101027},{"month":2,"riseRate":0.411765,"avgChangeRate":0.04937},{"month":3,"riseRate":0.294118,"avgChangeRate":-0.041326},{"month":4,"riseRate":0.588235,"avgChangeRate":0.056949},{"month":5,"riseRate":0.235294,"avgChangeRate":-0.027667},{"month":6,"riseRate":0.411765,"avgChangeRate":-0.038226},{"month":7,"riseRate":0.411765,"avgChangeRate":-0.045891},{"month":8,"riseRate":0.352941,"avgChangeRate":-0.009879},{"month":9,"riseRate":0.352941,"avgChangeRate":0.026985},{"month":10,"riseRate":0.352941,"avgChangeRate":-0.071025},{"month":11,"riseRate":0.352941,"avgChangeRate":-0.022185},{"month":12,"riseRate":0.352941,"avgChangeRate":-0.0158}],"exchange":"AMEX","name":"Protalix BioTherapeutics Inc","nameEN":"Protalix BioTherapeutics"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Protalix BioTherapeutics Inc(PLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Protalix BioTherapeutics Inc(PLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Protalix BioTherapeutics Inc,PLX,Protalix BioTherapeutics Inc股票,Protalix BioTherapeutics Inc股票老虎,Protalix BioTherapeutics Inc股票老虎国际,Protalix BioTherapeutics Inc行情,Protalix BioTherapeutics Inc股票行情,Protalix BioTherapeutics Inc股价,Protalix BioTherapeutics Inc股市,Protalix BioTherapeutics Inc股票价格,Protalix BioTherapeutics Inc股票交易,Protalix BioTherapeutics Inc股票购买,Protalix BioTherapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Protalix BioTherapeutics Inc(PLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Protalix BioTherapeutics Inc(PLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}